Jianmao Hong, Yanqiong Ye, Dingwen Zheng, Ximing Qian
{"title":"苦参胺a激活Akt/GSK-3β通路抑制氧化应激和炎症,减轻心肌缺血再灌注损伤","authors":"Jianmao Hong, Yanqiong Ye, Dingwen Zheng, Ximing Qian","doi":"10.2174/0115701808235958230923042422","DOIUrl":null,"url":null,"abstract":"Background:: Myocardial ischemia-reperfusion injury (MI/RI) is a serious complication after revascularization of myocardial infarction, which causes myocardium damage. Kukoamine A (KuA) can repress oxidative stress and neuronal apoptosis in cerebral ischemia animal models. background: Myocardial ischemia-reperfusion injury (MI/RI) is a serious complication after revascularization of myocardial infarction which causes myocardium damage. Kukoamine A (KuA) can repress oxidative stress and neuronal apoptosis in cerebral ischemia animal model. However, the role of KuA in MI/RI is not clear. Objective:: In the present study, our objective was to explore the role of KuA in MI/RI and the underlying mechanism of KuA in oxidative stress and inflammation of MI/RI. Methods:: H9c2 cells’ cytotoxicity was detected using the lactate dehydrogenase (LDH) assay kit. ROS level was measured by immunofluorescence. Male C57BL/6 mice were used to establish MI/RI mice by ligating the left anterior descending coronary artery (LAD). Results:: KuA treatment decreased the apoptosis and the cytotoxicity, increased the viability, and reduced the activities of myocardial infarction markers (CKMB, MYO, and cTnI) in hypoxia/ reoxygenation (H/R)-induced H9c2 cells. KuA reduced the levels of ROS, MDA, and inflammatory factors (IL-6, IL-1β, and TNF-α), and facilitated MMP and SOD levels in H/R-induced H9c2 cells. Besides, KuA activated Akt/GSK-3β axis, which was repressed by PI3K inhibitor LY294002. Moreover, KuA improved survival times, decreased the infarct size of mice, and recovered cardiac function in MI/RI mice. Finally, KuA alleviated MI/RI through Akt/GSK-3β pathway in vivo. Conclusion:: Thus, KuA exerts a protective function in MI/RI through the Akt/GSK-3β axis to repress oxidative stress and inflammation. other: none","PeriodicalId":18059,"journal":{"name":"Letters in Drug Design & Discovery","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Kukoamine a Activates Akt/GSK-3β Pathway to Repress Oxidative Stress and Inflammation to Alleviate Myocardial Ischemia-reperfusion Injury\",\"authors\":\"Jianmao Hong, Yanqiong Ye, Dingwen Zheng, Ximing Qian\",\"doi\":\"10.2174/0115701808235958230923042422\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background:: Myocardial ischemia-reperfusion injury (MI/RI) is a serious complication after revascularization of myocardial infarction, which causes myocardium damage. Kukoamine A (KuA) can repress oxidative stress and neuronal apoptosis in cerebral ischemia animal models. background: Myocardial ischemia-reperfusion injury (MI/RI) is a serious complication after revascularization of myocardial infarction which causes myocardium damage. Kukoamine A (KuA) can repress oxidative stress and neuronal apoptosis in cerebral ischemia animal model. However, the role of KuA in MI/RI is not clear. Objective:: In the present study, our objective was to explore the role of KuA in MI/RI and the underlying mechanism of KuA in oxidative stress and inflammation of MI/RI. Methods:: H9c2 cells’ cytotoxicity was detected using the lactate dehydrogenase (LDH) assay kit. ROS level was measured by immunofluorescence. Male C57BL/6 mice were used to establish MI/RI mice by ligating the left anterior descending coronary artery (LAD). Results:: KuA treatment decreased the apoptosis and the cytotoxicity, increased the viability, and reduced the activities of myocardial infarction markers (CKMB, MYO, and cTnI) in hypoxia/ reoxygenation (H/R)-induced H9c2 cells. KuA reduced the levels of ROS, MDA, and inflammatory factors (IL-6, IL-1β, and TNF-α), and facilitated MMP and SOD levels in H/R-induced H9c2 cells. Besides, KuA activated Akt/GSK-3β axis, which was repressed by PI3K inhibitor LY294002. Moreover, KuA improved survival times, decreased the infarct size of mice, and recovered cardiac function in MI/RI mice. Finally, KuA alleviated MI/RI through Akt/GSK-3β pathway in vivo. Conclusion:: Thus, KuA exerts a protective function in MI/RI through the Akt/GSK-3β axis to repress oxidative stress and inflammation. other: none\",\"PeriodicalId\":18059,\"journal\":{\"name\":\"Letters in Drug Design & Discovery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2023-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Letters in Drug Design & Discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115701808235958230923042422\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Letters in Drug Design & Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115701808235958230923042422","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:心肌缺血再灌注损伤(MI/RI)是心肌梗死血运重建术后的严重并发症,可引起心肌损伤。Kukoamine A (KuA)可以抑制脑缺血动物模型的氧化应激和神经元凋亡。背景:心肌缺血再灌注损伤(MI/RI)是心肌梗死血运重建术后引起的严重并发症。Kukoamine A (KuA)可以抑制脑缺血动物模型的氧化应激和神经元凋亡。然而,KuA在MI/RI中的作用尚不清楚。目的:在本研究中,我们的目的是探讨KuA在MI/RI中的作用以及KuA在MI/RI氧化应激和炎症中的潜在机制。方法:采用乳酸脱氢酶(LDH)测定试剂盒检测H9c2细胞的细胞毒性。免疫荧光法检测ROS水平。用雄性C57BL/6小鼠结扎左冠状动脉前降支(LAD)建立心肌梗死/心肌梗死小鼠。结果:KuA可降低缺氧/再氧化(H/R)诱导的H9c2细胞的凋亡和细胞毒性,提高细胞活力,降低心肌梗死标志物(CKMB、MYO和cTnI)的活性。KuA降低了H/ r诱导的H9c2细胞中ROS、MDA和炎症因子(IL-6、IL-1β和TNF-α)的水平,并促进了MMP和SOD的水平。此外,KuA激活Akt/GSK-3β轴,该轴被PI3K抑制剂LY294002抑制。此外,KuA改善了MI/RI小鼠的生存时间,减少了小鼠的梗死面积,并恢复了心功能。最后,KuA在体内通过Akt/GSK-3β通路缓解MI/RI。结论:由此可见,KuA通过Akt/GSK-3β轴对MI/RI具有抑制氧化应激和炎症的保护作用。其他:无
Kukoamine a Activates Akt/GSK-3β Pathway to Repress Oxidative Stress and Inflammation to Alleviate Myocardial Ischemia-reperfusion Injury
Background:: Myocardial ischemia-reperfusion injury (MI/RI) is a serious complication after revascularization of myocardial infarction, which causes myocardium damage. Kukoamine A (KuA) can repress oxidative stress and neuronal apoptosis in cerebral ischemia animal models. background: Myocardial ischemia-reperfusion injury (MI/RI) is a serious complication after revascularization of myocardial infarction which causes myocardium damage. Kukoamine A (KuA) can repress oxidative stress and neuronal apoptosis in cerebral ischemia animal model. However, the role of KuA in MI/RI is not clear. Objective:: In the present study, our objective was to explore the role of KuA in MI/RI and the underlying mechanism of KuA in oxidative stress and inflammation of MI/RI. Methods:: H9c2 cells’ cytotoxicity was detected using the lactate dehydrogenase (LDH) assay kit. ROS level was measured by immunofluorescence. Male C57BL/6 mice were used to establish MI/RI mice by ligating the left anterior descending coronary artery (LAD). Results:: KuA treatment decreased the apoptosis and the cytotoxicity, increased the viability, and reduced the activities of myocardial infarction markers (CKMB, MYO, and cTnI) in hypoxia/ reoxygenation (H/R)-induced H9c2 cells. KuA reduced the levels of ROS, MDA, and inflammatory factors (IL-6, IL-1β, and TNF-α), and facilitated MMP and SOD levels in H/R-induced H9c2 cells. Besides, KuA activated Akt/GSK-3β axis, which was repressed by PI3K inhibitor LY294002. Moreover, KuA improved survival times, decreased the infarct size of mice, and recovered cardiac function in MI/RI mice. Finally, KuA alleviated MI/RI through Akt/GSK-3β pathway in vivo. Conclusion:: Thus, KuA exerts a protective function in MI/RI through the Akt/GSK-3β axis to repress oxidative stress and inflammation. other: none
期刊介绍:
Aims & Scope
Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.